See more : Chin-Poon Industrial Co., Ltd. (2355.TW) Income Statement Analysis – Financial Results
Complete financial analysis of Omni Health, Inc. (OMHE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Omni Health, Inc., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Sinopec Shanghai Petrochemical Company Limited (600688.SS) Income Statement Analysis – Financial Results
- Shenzhen Breo Technology Co., Ltd. (688793.SS) Income Statement Analysis – Financial Results
- China Information Technology Development Limited (8178.HK) Income Statement Analysis – Financial Results
- Guodian Technology & Environment Group Corporation Limited (1296.HK) Income Statement Analysis – Financial Results
- Interconexión Eléctrica S.A. E.S.P. (IESFY) Income Statement Analysis – Financial Results
Omni Health, Inc. (OMHE)
About Omni Health, Inc.
Omni Health, Inc., through its subsidiary, Malecon Pharmacy, Inc., operates a pharmacy in Hialeah, Florida. It provides health, wellness, and pharmacy services; and manufactures, sells, and distributes anti-aging cream. The company is headquartered in Hialeah, Florida. Omni Health, Inc. is a subsidiary of LX Retail Group, Inc.
| Metric | 2016 | 2015 | 2014 |
|---|---|---|---|
| Revenue | 4.70M | 213.69K | 376.00K |
| Cost of Revenue | 3.14M | 186.18K | 206.53K |
| Gross Profit | 1.55M | 27.50K | 169.47K |
| Gross Profit Ratio | 33.07% | 12.87% | 45.07% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 561.53K | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 |
| SG&A | 1.15M | 561.53K | 201.85K |
| Other Expenses | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.15M | 561.53K | 203.19K |
| Cost & Expenses | 4.29M | 747.72K | 409.72K |
| Interest Income | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 21.96K | 1.47K | 1.33K |
| EBITDA | 1.29M | -532.57K | -32.39K |
| EBITDA Ratio | 9.10% | -249.23% | -8.61% |
| Operating Income | 405.52K | -534.03K | -33.72K |
| Operating Income Ratio | 8.64% | -249.91% | -8.97% |
| Total Other Income/Expenses | 860.12K | 0.00 | 0.00 |
| Income Before Tax | 1.27M | -534.03K | -33.72K |
| Income Before Tax Ratio | 26.96% | -249.91% | -8.97% |
| Income Tax Expense | -1.00 | 4.00 | 0.00 |
| Net Income | 1.27M | -534.03K | -33.72K |
| Net Income Ratio | 26.96% | -249.91% | -8.97% |
| EPS | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 972.23M | 516.06M | 500.14M |
| Weighted Avg Shares Out (Dil) | 972.23M | 516.06M | 500.14M |
Source: https://incomestatements.info
Category: Stock Reports